Tumours of pituitary origin compose about 30 % of all intracranial new growths (Love & Marshall 1950) . We must enquire not only into the actual tumours of the pituitary gland but into tumours of the pituitary stalk, for it may be quite impossible on clinical or radiological grounds to differentiate between them.
The diagnosis of pituitary tumour is based on bilateral visual field defects, primary optic atrophy and radiographic enlargement of the sella turcica. Each or all of these features may be absent, especially when a tumour arises in the presence of a pre-fixed optic chiasma. In practice, however, one is faced with greater conflict pathologically, for the diagnosis involves exclusion of numerous disorders associated with the development of a chiasmal syndrome. Fortunately it is possible by neurological and radiological means reasonably to exclude most of the other disorders. An enlarged sella turcica, even when accompanied by bitemporal field defects, may also arise from a dilated third ventricle due to a tumour within the posterior fossa (Fig 1) .
Differentiation between adenoma of the pituitary and craniopharyngioma: Distinguishing features which may be present are: (1) The age of the patient; this can be important as adenoma of the pituitary is not common in young children, particularly when there is raised intracranial pressure.
(2) Calcification in, or above, the sella turcica may be revealed by radiography in many cases of craniopharyngioma, being extremely rare within an adenoma ( Fig 2) . Mode of onset: The presentation of a case can vary, e.g. appearance in a child, growth disorder, visual deterioration, endocrine deficiency, headache; patients therefore tend to be referred through various channels. Delay in diagnosis: Delay has often been serious, as in the case of a young woman concerned with a menstrualupset who has been submitted to abdominal surgery before the basis of the disorder is revealed through irreversible visual deterioration.
Attention should be drawn to the amount of intracranial space available before encroachment upon important anatomical structures takes place. The infundibulum of the third ventricle or the optic chiasma may be one to two centimetres away from the diaphragma selle. With tumours (3) Other visual phenomena: Diplopia depends upon involvement of the III, IV or VI cranial nerves. Atrophy of the optic discs occurs in most cases where the optic nerves are in contact with the tumour, but can be absent in chiasmal or tract involvement. These attendant visual disorders allow a preoperative realization of the interrelationship between the tumour and the visual pathways, a matter of great importance in designing the scope of operation.
Endocrine dysfunction: In the past endocrine features were rarely in' themselves of surgical significance. It was not before encroachment by the tumour on adjacent structures beyond the sella that the neurosurgeon was even consulted. Nowadays, surgical relief in acromegaly may be sought, where clinical deterioration is uncontrolled by hormonal replacement. Meanwhile, operative treatment of Cushing's syndrome is directed more towards the adrenal gland, though deep therapy to the pituitary continues to play some part. TREATMENT 
Craniopharyngioma
Preliminary air studies are essential in the proper management of a craniopharyngioma, for the extent of ventricular encroachment and dilatation must be determined before operation ,an be planned.
The operative approach will be by either a subfrontal or a transventricular route. If there are field defects the optic nerve and chiasma should be inspected. Cystic tumours: Evacuation of a purely cystic mass may be all that is required, but a small portion of capsule should be excised for histological examination and the prevention of cohesion between the margins. A cystic neoplasm may unfortunately be composed of an aggregation of small cysts many of which are too small to require evacuation. Such a conformation may permit a recurrence of symptoms, sometimes months but generally years later. Should a cystic Lumour not respond satisfactorily to aspiration, marsupialization of its cavity into the lateral ventricle may be feasible (Scarff 1941) . Solid tumour: Only as a very last resort would one consider undertaking resection of a solid tumour, and any portion of tumour tissue abutting on the hypothalamus should be left undisturbed.
Internal hydrocephalus is to be relieved by shortcircuiting the obstruction, a tube being introduced to connect the lateral ventricle with the cisterna magna (Torkildsen 1939) .
Pituitary Adenomata
Chromophil adenomata are much less common than the chromophobe form. Operative treatment may be carried out purely to control endocrine disorder, but it has long been used for the relief of headache and visual disorder. Headache is especially troublesome and intense in patients with chromophil tumours. Basophil adenoma: Attention is directed more towards the adrenals, though deep irradiation of the pituitary gland has been applied in Cushing's disorder (Cohen & Dible 1936) . Chromophobe adenoma, being of much commoner occurrence, is our main concern. These tumours regularly arise within the sella, and it is not until they escape therefrom that surgical considerations arise. The majority of tumours call for attention on account of visual deterioration. Headache is an important feature but usually not as severe as in the case of chromophilic growths.
Nevertheless, not all chromophobe adenomata are as restricted in their encroachment. Indeed, they are prone to extend along any of the available channels of spread, and in almost any direction, to give rise to signs relative to structures encountered en route (Table 1) . The preponderant clinical signs may actually over-shadow those of the primary disorder. Not detectable clinically the crus and pons towards the posterior fossa Nasal or nasopharyngeal, Epistaxis, CSF rhinorrhcea after eroding the base of the skull It used to be said that extrasellar extension of an adenoma indicated malignant change; later this was altered to invasive. Neither term is intrinsically correct, although operative treatment has been attended by a disturbing mortality rate. Whereas with straightforward circumscribed tumours a mortality rate of 2 % or less can reasonably be expected, a figure of 35 % or more resulted where extensions occurred. One can well understand that such lesions were deemed inoperable (Jefferson 1940 , Henderson 1939 (Figs 3-6 ). There are two special features among others underlying such disasters: the technical requirement of a hazardous dissection of vital cerebral vessels that cannot be changed, and the coexistence of pituitary insufficiency. Malignant adenoma: This is a very uncommon form of carcinoma which is invasive and may metastasize elsewhere in the body (Fig 7) .
Surgery may be carried out using either a transfrontal or a transsphenoidal approach.
The transfrontal operation of the Frazier type is the operation of general choice where an adenoma extends beyond the sella turcica. Naturally, when a tumour extends farther, a fuller exposure is necessary. Should a frontal extension exist, the exposure of the frontal pole must be such as to permit of its resection, if necessary. Extension into the middle fossa needs a wider exposure of the temporal lobe.
The transsphenoidal operation is a surgical approach which should be restricted to cases where the growth does not extend beyond the diaphragma selhe. It is useful, therefore, in cases of acromegaly, for hypophysectomy in the relief of disseminated carcinomatosis, and where tumours erode the base of the skull, encroaching on the sphenoidal sinus, the nose, or the nasopharynx. Hypopituitarism must be counteracted by appropriate endocrine replacement both before and after operation. This permits one to operate upon cases of extended tumours with much less apprehension on the part of the surgeon, and much greater tolerance on the part of the patient.
Deep X-ray therapy should not be looked upon as a primary method of treatment unless some contraindication to operation exists, e.g. a disorder of general health, or if the patient refuses operation. On the other hand, operative treatment should always be followed by a course of deep X-ray therapy in adenomatous tumours.
I am very doubtful whether any benefit accrues from applying deep X-ray therapy in cases of craniopharyngioma. Of recent years, efforts have been made to treat craniopharyngiomata by the implantation of radioactive isotopes, particularly gold. Even ,-radiation has been tried in the implantation of yttrium seeds, with a view to direct destruction of tumour tissue. Such methods are still experimental.
Dr J A C Fleming (Radiotherapy Department, St Thomas's Hospital, London) Treatment ofPituitary Tumours by External Irradiation Most patients with pituitary tumours sent for external irradiation have chromophobe adenomata. Of 220 cases reviewed by Richmond (1958) about 80% belonged to this category; 8% were cases of eosinophil tumour.
Recent reports confirm previous impressions that the radiosensitivity of these tumours varies in proportion to the magnitude of the radiation dose delivered to the gland. Colby et al. (1964) and Paterson (1963) mentioned difficulties in evaluating the response to treatment of chromophobe adenoma in terms of measurable criteria, other than changes in visual field impairment.
Over the last fourteen years, two methods of external irradiation have been used at St Thomas's Hospital:
(1) Initially by orthovoltage 250 kV X-rays, employing narrow beams of about 5 cm crosssectional diameter. After accurate localization of the sella to reference marks on the skin, checked radiologically, the beams were directed through five or six skin fields around the scalp and aimed to 'cross fire' the sella.
(2) Since 1957 similarly narrow beams of y-rays from a cobalt teletherapy unit have been used. Although slightly heavier doses are applied with y-rays to compensate for their less damaging effect upon all tissues, as compared with orthovoltage X-rays, evidence to suggest that the y-rays exert superior biological effects upon these tumours is lacking. Greater physical penetration of cobalt y-rays through tissue with much reduced skin damage has, however, enabled adequate tumour dosage to be delivered through only three skin fields, with resulting increased accuracy, negligible skin reaction and less disturbance to the patient.
Patients Treated
Forty patients with pituitary tumours have been treated by radiotherapy over the last ten years. Information is available on the progress of only 23 of these for one year or more following treatment. Eighteen of the 23 had chromophobe or mixed tumours and all except 5, of whom 3 were acromegalic, were referred after some form of operative surgery. Conclusions on efficacy of treatment cannot be drawn from such limited material, but the control rate does not seem to differ materially from other published results.
Dosage and Complications
Before 1953 pituitary adenomata were treated by orthovoltage X-rays to total average tumour doses of about 4,000-5,000 rads given in twenty fractions over about twenty-eight days, without any known complications. From 1953 to 1957 this dose rarely exceeded 4,200 rads.
In August 1957 a patient was referred to me with an eight-year history of acromegaly associated with a pituitary adenoma; no surgery had
